Weigh the Benefits and Risks of Vyvanse in Binge-Eating Patients

Vyvanse (lisdexamfetamine) is now approved for moderate to severe binge eating disorder in adults...not just for ADHD.

About 1 in 70 adults have a binge eating disorder. These patients have frequent episodes of compulsive, out-of-control overeating...that often lead to obesity and mood disorders.

When suggesting a treatment, consider availability, cost, patient preference, and other comorbid conditions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote